APA

Bignon E., Bachy A., Boigegrain R., Brodin R., Cottineau M., Gully D., Herbert J. M., Keane P., Labie C., Molimard J. C., Olliero D., Oury-Donat F., Petereau C., Prabonnaud V., Rockstroh M. P., Schaeffer P., Servant O., Thurneyssen O., Soubrié P., Pascal M., Maffrand J. P. & Le Fur G. (19990520). SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I. In vitro studies. : The Journal of pharmacology and experimental therapeutics.

Chicago

Bignon E, Bachy A, Boigegrain R, Brodin R, Cottineau M, Gully D, Herbert J M, Keane P, Labie C, Molimard J C, Olliero D, Oury-Donat F, Petereau C, Prabonnaud V, Rockstroh M P, Schaeffer P, Servant O, Thurneyssen O, Soubrié P, Pascal M, Maffrand J P and Le Fur G. 19990520. SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I. In vitro studies. : The Journal of pharmacology and experimental therapeutics.

Harvard

Bignon E., Bachy A., Boigegrain R., Brodin R., Cottineau M., Gully D., Herbert J. M., Keane P., Labie C., Molimard J. C., Olliero D., Oury-Donat F., Petereau C., Prabonnaud V., Rockstroh M. P., Schaeffer P., Servant O., Thurneyssen O., Soubrié P., Pascal M., Maffrand J. P. and Le Fur G. (19990520). SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I. In vitro studies. : The Journal of pharmacology and experimental therapeutics.

MLA

Bignon E, Bachy A, Boigegrain R, Brodin R, Cottineau M, Gully D, Herbert J M, Keane P, Labie C, Molimard J C, Olliero D, Oury-Donat F, Petereau C, Prabonnaud V, Rockstroh M P, Schaeffer P, Servant O, Thurneyssen O, Soubrié P, Pascal M, Maffrand J P and Le Fur G. SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I. In vitro studies. : The Journal of pharmacology and experimental therapeutics. 19990520.